The US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) has started working on a clinical trial to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19). The Phase 2b trial will enroll approximately 2,000 adults across the United ...

Read More »